Charles Schwab’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-2,318
| Closed | -$31K | – | 3651 |
|
2021
Q4 | $31K | Hold |
2,318
| – | – | ﹤0.01% | 3545 |
|
2021
Q3 | $102K | Buy |
2,318
+1,148
| +98% | +$50.5K | ﹤0.01% | 3378 |
|
2021
Q2 | $49K | Sell |
1,170
-7,284
| -86% | -$305K | ﹤0.01% | 3376 |
|
2021
Q1 | $410K | Buy |
8,454
+463
| +6% | +$22.5K | ﹤0.01% | 3141 |
|
2020
Q4 | $785K | Hold |
7,991
| – | – | ﹤0.01% | 2844 |
|
2020
Q3 | $552K | Sell |
7,991
-268
| -3% | -$18.5K | ﹤0.01% | 2847 |
|
2020
Q2 | $873K | Buy |
8,259
+1,184
| +17% | +$125K | ﹤0.01% | 2659 |
|
2020
Q1 | $629K | Buy |
7,075
+939
| +15% | +$83.5K | ﹤0.01% | 2636 |
|
2019
Q4 | $701K | Buy |
6,136
+713
| +13% | +$81.5K | ﹤0.01% | 2708 |
|
2019
Q3 | $336K | Buy |
5,423
+1,231
| +29% | +$76.3K | ﹤0.01% | 2943 |
|
2019
Q2 | $327K | Buy |
4,192
+327
| +8% | +$25.5K | ﹤0.01% | 2982 |
|
2019
Q1 | $522K | Buy |
3,865
+324
| +9% | +$43.8K | ﹤0.01% | 2749 |
|
2018
Q4 | $285K | Buy |
3,541
+294
| +9% | +$23.7K | ﹤0.01% | 2953 |
|
2018
Q3 | $341K | Sell |
3,247
-200
| -6% | -$21K | ﹤0.01% | 2967 |
|
2018
Q2 | $345K | Sell |
3,447
-2,850
| -45% | -$285K | ﹤0.01% | 2916 |
|
2018
Q1 | $794K | Buy |
6,297
+685
| +12% | +$86.4K | ﹤0.01% | 2592 |
|
2017
Q4 | $938K | Buy |
5,612
+2,032
| +57% | +$340K | ﹤0.01% | 2527 |
|
2017
Q3 | $1.13M | Hold |
3,580
| – | – | ﹤0.01% | 2473 |
|
2017
Q2 | $1.06M | Buy |
3,580
+2,555
| +249% | +$759K | ﹤0.01% | 2431 |
|
2017
Q1 | $237K | Buy |
+1,025
| New | +$237K | ﹤0.01% | 2898 |
|
2016
Q2 | – | Sell |
-950
| Closed | -$108K | – | 3152 |
|
2016
Q1 | $108K | Hold |
950
| – | – | ﹤0.01% | 2982 |
|
2015
Q4 | $146K | Hold |
950
| – | – | ﹤0.01% | 3011 |
|
2015
Q3 | $104K | Hold |
950
| – | – | ﹤0.01% | 3030 |
|
2015
Q2 | $136K | Buy |
950
+385
| +68% | +$55.1K | ﹤0.01% | 3030 |
|
2015
Q1 | $186K | Hold |
565
| – | – | ﹤0.01% | 2967 |
|
2014
Q4 | $229K | Buy |
+565
| New | +$229K | ﹤0.01% | 2946 |
|